Tactile Medical signs exclusive VA, DoD distribution deal with ElastiMed for MyoSleeve device
TCMD•Device clearance and intended use
- MyoSleeve has FDA 510(k) clearance.
- It is positioned for earlier-stage patients or as a complement to pneumatic compression therapy.
Upfront payment and commercial terms
- Tactile paid ElastiMed an upfront $3 million.
- The agreement includes minimum purchase commitments, marketing support, and sales promotion obligations.
Exclusive distribution agreement for MyoSleeve
- Tactile Systems Technology entered an exclusive U.S. distribution agreement with ElastiMed for its MyoSleeve wearable lower-leg compression device.
- The deal grants exclusive rights to distribute MyoSleeve within U.S. VA and DoD systems for patients with chronic swelling conditions.
